Trinity Biotech (TRIB)
(Delayed Data from NSDQ)
$2.10 USD
0.00 (0.00%)
Updated Jun 7, 2024 03:59 PM ET
After-Market: $2.10 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth D Momentum B VGM
Brokerage Reports
0 items in cart
Trinity Biotech PLC [TRIB]
Reports for Purchase
Showing records 61 - 80 ( 102 total )
Company: Trinity Biotech PLC
Industry: Medical - Products
Healthcare - 2Q 2013: Quarterly Medical Technology Trading & Acquisition Update
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Trinity Biotech PLC
Industry: Medical - Products
Company: Trinity Biotech PLC
Industry: Medical - Products
Core Business Soft; Offset by Progress w/ Premier & Fiomi; Neutral
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Trinity Biotech PLC
Industry: Medical - Products
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Trinity Biotech PLC
Industry: Medical - Products
1Q Preview: EPS Inline or a Penny Better; Same Outlook
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Trinity Biotech PLC
Industry: Medical - Products
1Q13 MedTech Preview: ALGN ICUI TRIB CRY CPTS ATEC RTIX SLTM VOLC ATRC (Part 1)
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Trinity Biotech PLC
Industry: Medical - Products
Healthcare - 1Q 2013: Quarterly Medical Technology Trading & Acquisition Update
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Trinity Biotech PLC
Industry: Medical - Products
4Q Light but Outlook & Pipeline on Track; Raising Target - Neutral
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Trinity Biotech PLC
Industry: Medical - Products
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Trinity Biotech PLC
Industry: Medical - Products
Updating Model for Tax ? Stepping to Sideline After Great Run
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Trinity Biotech PLC
Industry: Medical - Products
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Trinity Biotech PLC
Industry: Medical - Products
Inline 3Q; Reasonable Val?n - Premier, New Products Offer Upside
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Trinity Biotech PLC
Industry: Medical - Products
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Trinity Biotech PLC
Industry: Medical - Products
3Q Preview: Inline to Modest Upside;Premier On Track
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Trinity Biotech PLC
Industry: Medical - Products
Company: Trinity Biotech PLC
Industry: Medical - Products
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Trinity Biotech PLC
Industry: Medical - Products
Positive Takeaways from AACC - Future Looks Promising
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Trinity Biotech PLC
Industry: Medical - Products
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Trinity Biotech PLC
Industry: Medical - Products
Testing New Highs - Raising PT on Good 2Q; Growth Improvement to Continue
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Trinity Biotech PLC
Industry: Medical - Products
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.